(Q54499924)

30 May 2018

title

Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice (English)

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

main subject

Mycobacterium marinum

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

author name string

J. L. Krahenbuhl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343295

3 October 2023

R. C. Humphres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343295

3 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6343295

3 October 2023

publication date

1 April 1983

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0162310983900486?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

https://api.elsevier.com/content/article/PII:0162310983900486?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

1 reference

30 May 2018

volume

5

1 reference

30 May 2018

issue

4

1 reference

30 May 2018

page(s)

329-339

1 reference

30 May 2018

Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Modulation of the immune response by a synthetic adjuvant and analogs

3 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

3 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Corynebacterium parvum: a Synonym for Propionibacterium acnes?

3 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-alanyl-d-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice

3 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

3 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

The macrophage, target cell of the synthetic adjuvant muramyl dipeptide

3 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Failure of synthetic muramyl dipeptide to increase antibacterial resistance

3 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

3 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide

3 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Resistance to Mycobacterium leprae in Mice Infected with Toxoplasma gondii and Besnoitia jellisoni.

3 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes

3 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: Factors affecting the response

3 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components

3 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

The influence of immunologically committed lymphoid cells on macrophage activity in vivo

3 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Analogy of Mycobacterium marinum Disease to Mycobacterium leprae Infection in Footpads of Mice

3 October 2023

26

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor

3 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse

3 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Macrophage activation by bacterial cell walls and related synthetic compounds

3 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide

3 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0162-3109(83)90048-6

3 October 2023

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018